These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7076441)

  • 1. Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent.
    Marincek B; Young SW; Enzmann DR
    Invest Radiol; 1982; 17(1):90-4. PubMed ID: 7076441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of iosulamide meglumine as a contrast material for intravenous cholangiography: an experimental study in dogs.
    Berk RN; Barnhart JL; Nazareno G; Witt BL
    Invest Radiol; 1981; 16(3):240-4. PubMed ID: 7263160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iosulamide: a new intravenous cholangiocholecystographic medium.
    Rosenberg FJ; Ackerman JH; Nickel AR
    Invest Radiol; 1980; 15(6 Suppl):S142-7. PubMed ID: 6782035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. II: The renal medulla.
    Brennan RE; Curtis JA; Pollack HM; Weinberg I
    Invest Radiol; 1979; 14(3):239-45. PubMed ID: 468497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion.
    Blomley MJ; Coulden R; Bufkin C; Lipton MJ; Dawson P
    Invest Radiol; 1993 Nov; 28 Suppl 5():S72-7; discussion S78. PubMed ID: 8282508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT densities in delayed iodine hepatic scanning.
    Perkerson RB; Erwin BC; Baumgartner BR; Phillips VM; Torres WE; Clements JL; Gedgaudas-McClees K; Bernardino ME
    Radiology; 1985 May; 155(2):445-6. PubMed ID: 3983398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed iodine scanning of the liver: a promising CT technique.
    Phillips VM; Erwin BC; Bernardino ME
    J Comput Assist Tomogr; 1985; 9(2):415-6. PubMed ID: 3973182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast enhancement of the liver and blood. Nonionic versus ionic contrast media in the pig.
    Jensen LI; Golman K; Nyman U; Dean PB
    Invest Radiol; 1985 Dec; 20(9):989-94. PubMed ID: 4077451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion.
    Dean PB; Violante MR; Mahoney JA
    Invest Radiol; 1980; 15(2):158-61. PubMed ID: 7372426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of iosulamide to enhance hepatic tumors in rats.
    Burgener FA; Ciaravino V; Fischer HW
    Invest Radiol; 1982; 17(1):46-9. PubMed ID: 7076433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast media for computer tomography of the liver.
    Wegener OH; Mützel W; Souchon R
    Acta Radiol Diagn (Stockh); 1980; 21(2A):239-47. PubMed ID: 7424559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental hepatosplenography after the administration of liposomes with verografin].
    Aliiakparov MT; Rozenberg OA; Fomina EV; Loshakova LV; Gubareva AV
    Med Radiol (Mosk); 1981 Nov; 26(11):45-8. PubMed ID: 7321787
    [No Abstract]   [Full Text] [Related]  

  • 13. Iosulamide: human tolerance study of a new intravenous cholangiographic drug.
    Nelson JA; White GL; Nakashima EN
    Invest Radiol; 1980; 15(6):511-6. PubMed ID: 7203907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhancement of the liver. Evaluation by automated contiguous pixel search.
    Stude RA; Hedlund LW; Johnson GA; Thompson WM
    Invest Radiol; 1987 Feb; 22(2):132-6. PubMed ID: 3030962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
    Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
    AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of pharmacokinetics to computed tomography: injection rates and schemes: mono-, bi-, or multiphasic?
    Krause W
    Invest Radiol; 1996 Feb; 31(2):91-100. PubMed ID: 8750444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT.
    Paajanen H; Kormano M
    Eur J Radiol; 1985 Aug; 5(3):243-5. PubMed ID: 3896802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impermeability of the blood-brain barrier to intravenous high-iodine-dose meglumine diatrizoate in the normal dog.
    Hayman LA; Pagani JJ; Serur JR; Hinck VC
    AJNR Am J Neuroradiol; 1984; 5(4):409-11. PubMed ID: 6205572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic hepatic CT: uniphasic and biphasic contrast medium injection protocols.
    Drop A
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():195-204. PubMed ID: 11205764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.